Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Switch to FNB Business

Product shop

By Turnover

First Business Zero (R0 - R1 million p.a) Gold Business (R0 - R5 million p.a) Platinum Business (R5 million - R60 million p.a) Enterprise Business (R60 million - R150 million+ p.a)

Transact

Business Accounts Credit Cards Cash Solutions Merchant Services eWallet Pro Staffing Solutions ATM Solutions Ways to bank Fleet Services Guarantees

Savings and Investments

Save and Invest 3PIM (3rd Party Investment Manager)

Borrow

FNB Cash Advance Overdraft Loans Debtor Finance Leveraged Finance Private Equity Securities Based Lending Selective Invoice Discounting Asset Based Finance Alternative Energy Solutions Commercial Property Finance Fleet Services

Insure

Insurance

For my employees

Staffing Solutions Employee benefits

Forex + Trade

Foreign Exchange Imports and exports Structured Trade + Commodity Finance Business Global Account (CFC account)

Value Adds + Rewards

Connect my business the dti initiatives Enterprise and supplier development Business Hub eBucks Rewards for Business DocTrail™ CIPC Integration Channel Instant Accounting Solutions Instant Payroll Instant Cashflow Instant Invoicing SLOW 24/7 Business Desk FNB Business Fundaba nav» Marketplace Prepaid products Accounting integrations

Industry Expertise

Philanthropy Chinese Business Islamic Banking Agriculture Public Sector Education Healthcare Franchise Motor Dealership Tourism

Going Global

Global Commercial Banking

Financial Planning

Overview

Bank Better

KYC / FICA Debit order + recipient switching Electronic Alerts

Corporates + Public Sector

Corporate Public Sector

All savings + investment accounts


Cash deposits

Notice deposits Immediate access Access to a portion Fixed deposits

Share investing

Shares

Tax-free investing

Tax-free accounts

Funds/unit trusts

Ashburton specialised products

Invest abroad

Offshore products

I want to save for

Personal goals Child's education Emergencies Tax-free

Compare similar

Compare

Additional options

Show me all Help me chosse Find an advisor

Financial planning

Overview

Back

Trade Ideas

Local Trade Idea: Dis-Chem Pharmacies (DCP) - BUY

 

By Peet Serfontein & Pritu Makan

Dis-Chem is one of the leading pharmaceutical and consumer wellness groups in South Africa. The company takes a 'Pharmacy First' approach with the main aim of serving the primary pharmaceutical needs of individuals. Other products on offer include personal and beauty products, health, nutrition and baby care products, as well as confectionery, dry grocery, household and other ancillary goods. The group utilises its wholesale business to service third parties and Dis-Chem retail pharmacies through its CJ distribution business.

Technically, the price is in a developing symmetrical triangle pattern, which makes the share an interesting candidate for a long position (see black converging trendlines on the main chart). The price appears to be progressing into wave five of the developing symmetrical triangle, suggesting that the consolidation phase is nearing completion. This stage often precedes a decisive breakout.

Furthermore, the price distribution chart for DCP supports a bullish case given that the current price of R32.60 is situated within one of the most heavily traded and high-frequency zones over the last five years (see insert on main chart).

The price is trading above its 200-week simple moving average (SMA), but below its 200-day SMA - the level of the 200-day is at R33.54. This is generally seen as a form of long-term bullish support.

Upside momentum, as indicated by the Moving Average Convergence Divergence (MACD) histogram, supports the trade idea.

Share Information
Share Code DCP
Industry Consumer Staples Distribution
Market Capital (ZAR) 28.04 billion
One Year Total Return -8.49%
Return Year-to-Date -8.90%
Current Price (ZAR) 32.60
52 Week High (ZAR) 40.00
52 Week Low (ZAR) 26.50
Financial Year End February
While the share has come under pressure year-to-date, technical indicators are pointing towards a potential near-term recovery in the share price.

Consensus Expectations (Bloomberg)
FY25 FY26E FY27E FY28E
Headline Earnings per Share (ZAR) 1.37 1.53 1.82 2.14
Growth (%) 11.57 18.98 17.21
Dividend Per Share (ZAR) 0.55 0.61 0.73 0.87
Growth (%) 11.11 18.85 20.28
Forward PE (times) 21.27 17.87 15.25
Forward Dividend Yield (%) 1.87 2.22 2.67
Attractive double-digit earnings growth is expected over the forecast horizon.

Buy/Sell Rationale:

Technical Analysis:

    • The lower panel shows the Bollinger Band bandwidth for the share - this measures the percentage difference between the upper and lower Bollinger Bands, essentially quantifying how wide or narrow the bands are relative to the price. As the bandwidth contracts to a low reading (see black arrow), it signals that volatility has compressed, often after an extended consolidation phase. Such conditions frequently precede a significant breakout (our bias is to the upside given the broader positive technical context), as the price rarely stays in a low-volatility environment for long.
    • The recent sideways trajectory according to the On-balance volume (OBV) indicator supports a bullish undertone.
    • Our recommended entry range for this trade is between R32 to R33 - a drop below this range would indicate a structural change in the trend, giving reason to negate the idea.
    • Our target price is R37, representing upside potential of ~13.5% from current levels.
    • Our proposed time to exit is towards the end of October 2025, though investors can adjust for either a longer or shorter time horizon, depending on price behaviour.
    • A drop below R31 (downside of ~4.9% from current levels) would imply weakening technicals. As such, a stop-loss is recommended at this level.
    • We expect moderate volatility going forward and suggest a medium capital at-risk allocation to this trade. Increase exposure for a break above R33.

Fundamental view

    • We are positive on the health and beauty retail space in the South African context. Within this area, the company is the market leader in Dispensary, Vitamins and Supplements, and Healthcare and Nutrition. Other products on offer include personal and beauty products, health, nutrition, and baby care products, as well as confectionery, dry grocery, household and other ancillary goods.
    • Private label accounts for a big portion of sales, with the possibility of increasing over time and these products tend to carry higher margins.
    • Dis-Chem's franchise model, The Local Choice (TLC), is an interesting differentiator for the business and is growing quickly. This is driving supply-chain volumes, and perhaps margins, in CJ distribution.
    • Dis-Chem delivered a fair performance in FY25 to the end of February, with HEPS growth comfortably surpassing market expectations at the time. Revenue grew slightly below consensus, while operating profit rose by more than anticipated due to strong cost control (particularly on payrolls). While retail growth was subdued, the strong performance in wholesale was again complimented by independent pharmacies and TLC. The company increased its dividend by 19.9%.
    • Looking ahead to FY26, management remains focused on strategic growth through store expansion, digital transformation, and operational efficiency. However, the leadership said the group expects that the consumer will remain constrained due to the current economic climate. For the three-month period 1 March to 27 May, group revenue grew by 8.6% y/y.
    • Risks to our fundamental view include persistent macroeconomic pressure, bumpy store-rollouts (revenue growth could be lower compared to current market assumptions). Cannibalisation and persistent competition are also key risks.

Share Name and Position GRT - Buy
(Continue to hold)
SBK - Buy
(Continue to hold)
RDF - Buy
(Continue to hold)
Entry 13.22 233.57 4.69
Current Price 14.80 250.40 4.94
Movement +12.0% +7.2% +5.3%
Comment The share is trading in one of the highest price bins of the price distribution analysis which remains of interest. Remains above its 200-day SMA. Upside momentum supports the trade. Our profit target remains at R16.00 with a trailing stop-loss at R14.00. The price is holding above key support. Crossed and remains above its 200-day SMA. Upside momentum supports the trade. We maintain our profit target at R261.00 and with a trailing stop-loss at R240.00. The price is in a developing triangle pattern. Remains above its 200-day SMA. Upside momentum supports the trade. Our profit target remains at R5.30 with a trailing stop-loss at R4.70.
Time to exit 17 November 2025 19 January 2026 1 September 2025

Share Name and Position VAL - Buy
(Continue to hold)
BID - Buy
(Continue to hold)
TBS - Buy
(Continue to hold)
Entry 850.00 458.43 304.50
Current Price 865.53 464.02 308.00
Movement +1.8% +1.2% +1.1%
Comment The price is developing a rounding top pattern. Remains above its 200-day simple moving average. Fading upside momentum is a concern. Our profit target remains at R1 063.00 with a stop-loss at R758.00. The combination of a sustained bounce off the lower one standard deviation band, ongoing support from the broader upward trend and signs of renewed buying interest remains of interest. Remains above its 200-day SMA. Fading downside momentum supports the trade. Our profit target remains at R528.00 with a stop-loss at R437.00. The price movement is aligned with a rising Volume Price Trend (VPT), backed by sustained accumulation and buying interest. Remains above its 200-day simple moving average. Fading downside momentum supports the trade strategy. We maintain our profit target at R345.00 with a trailing stop-loss at R292.00.
Time to exit 10 September 2025 30 August 2025 27 October 2025

Share Name and Position STXFIN - Buy
(Continue to hold)
COH - Buy
(Approaching time exit)
Entry 21.75 8.82
Current Price 21.98 8.31
Movement +1.1% -5.8%
Comment The price remains above major support. Remains just above its 200-day SMA. Upside momentum supports the trade. We maintain our profit target at R25.00 with a stop-loss at R20.75. The price is at a key distribution level. Remains below its 200-day SMA, marking this as a counter-trend setup. Muted upside momentum supports the trade. We maintain our profit target at R10.50 with a stop-loss at R8.20.
Time to exit 15 September 2025 22 August 2025

FNB Stockbroking and Portfolio Management (Pty) Ltd, a subsidiary of FirstRand Bank Limited, an authorised Financial Services Provider and authorised user of the JSE limited (Reg no: 1996/011732/07). This Publication note is issued by FNB Stockbroking and Portfolio Management (Pty) Ltd for the information of clients only and should not be produced in whole or part without prior permission. Although FNB Stockbroking and Portfolio Management (Pty) Ltd is an Authorised Financial Services Provider, any opinions and/or analysis contained in this Publication are for informational purposes only and should not be considered advice, including but not limited to financial, legal or tax advice, or a recommendation to invest in any security or to adopt any investment strategy. The information contained herein has been obtained from sources/persons which we believe to be reliable but is not guaranteed for correctness, completeness or otherwise and we do not assume liability for loss arising from errors in the information or that may be suffered from using or relying on the information contained herein irrespective of whether there has been any negligence by us, our affiliates or any other employees of us, and whether such losses be direct or consequential. As market and economic conditions are subject to rapid change, any comments, opinions, and analysis is rendered as of the date of publishing and may change without notice. Such changes may have a material impact on the outcome of any investment. Securities involve a degree of risk and are volatile instruments. Past performance is not indicative of future performances. Securities or financial instruments mentioned in the Publication note may not be suitable for all investors and FNB Stockbroking and Portfolio Management (Pty) Ltd has bares no responsibility whatsoever arising from or as a consequence hereof. The material is not intended as a complete analysis of every material fact regarding any share, instrument, sector, region, market, country, investment, or strategy. The recipient of this Publication must make their own investment decision and is advised to contact his relationship manager for a personal financial analysis prior to making any investment decisions. Copyright 2018 by FNB Stockbroking and Portfolio Management (Pty) Ltd.

How would you like to log in?